Jazz Pharmaceuticals’ (JAZZ) Buy Rating Reiterated at Needham & Company LLC
Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report)‘s stock had its “buy” rating reaffirmed by Needham & Company LLC in a report issued on Wednesday,Benzinga reports. They currently have a $202.00 target price on the specialty pharmaceutical company’s stock. Needham & Company LLC’s price objective indicates a potential upside of 83.15% from the company’s previous close. […]
Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report)‘s stock had its “buy” rating reaffirmed by Needham & Company LLC in a report issued on Wednesday,Benzinga reports. They currently have a $202.00 target price on the specialty pharmaceutical company’s stock. Needham & Company LLC’s price objective indicates a potential upside of 83.15% from the company’s previous close. […]
